Clinical trial Recruiting at 1 site Interventional Ages 21 and up

Improving sleep in adults with cannabis use issues

Official title: Targeting Insomnia to Improve Outcomes in Adults With Problematic Cannabis Use

Run by University of Michigan · NCT05814822 · Data updated 2026-11-12

This study is testing whether a special online therapy for sleep problems can help adults who use cannabis for sleep feel better and sleep more soundly compared to regular sleep education.

Quick facts

Study typeInterventional
Ages21 Years and up
SexAll
Enrollment200 (estimated)
SponsorUniversity of Michigan
Academic / other
Locations1 site (Ann Arbor, Michigan)
StatusRecruiting
StartedJune 1, 2023
Main results expectedJuly 31, 2027
Study endsJuly 31, 2027
Registry record updatedMay 22, 2026
Trial IDNCT05814822 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults with chronic insomnia who use cannabis at least three times a week to manage their sleep issues.

Probably not a fit

Patients with other significant sleep disorders or severe mental health conditions may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study compares the effectiveness of telemedicine-delivered cognitive behavioral therapy for insomnia specifically designed for individuals using cannabis for sleep against telemedicine-delivered sleep hygiene education. It aims to assess improvements in sleep quality, cannabis use, and daytime functioning. Additionally, the study will evaluate the impact of the cognitive behavioral therapy on the body's sleep regulatory system and its correlation with clinical outcomes.

Why it matters

Potential benefit: If successful, this study could lead to improved sleep quality and reduced cannabis dependency for patients struggling with insomnia.

How similar studies have gone: Other studies have shown promising results with cognitive behavioral therapy for insomnia, suggesting potential success for this tailored approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
INCLUSION CRITERIA

* 21 years of age and older, the age needed to obtain full legal access to cannabis in Michigan
* Self-reported chronic insomnia (nighttime symptoms of difficulty initiating and/or maintaining sleep and/or early morning awakenings on ≥3 nights for ≥3 months with daytime impairment), consistent with DSM-5 diagnosis of Insomnia Disorder
* Insomnia Severity Index (ISI) score ≥11, indicative of at least "mild" insomnia
* A positive urine drug screen (UDS) for cannabis33
* Self-reported use of cannabis at least three times weekly for the past month
* Stable residence (e.g., stable sleep arrangements), consistent access to Wi-Fi, and ability to travel to Ann Arbor for sleep laboratory assessments

EXCLUSION CRITERIA

* Individuals who do not understand English (read and spoken)
* Individuals judged unable to provide informed consent (e.g., intoxication, mental incompetence)
* Diagnosis or high suspicion of a sleep disorder other than insomnia
* Lifetime diagnosis of psychotic disorder or bipolar disorder; current post-traumatic stress disorder that directly interferes with sleep
* Terminal or progressive physical illness (e.g., cancer) or neurological degenerative disease (e.g., dementia)
* Use of medications known to have initiated their insomnia (e.g., steroids)
* Previous receipt of CBTi
* Self-reported pregnancy
* Self-reported regular work schedule of rotating or night (3rd) shift work
* Other conditions and situations, medical or otherwise, that preclude meaningful and/or safe participation in CNT/SHE and study procedures

Where it's running

  • University of Michigan
    Ann Arbor, Michigan, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.